Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 1536

1.

Switching to coformulated rilpivirine (RPV), emtricitabine (FTC) and tenofovir alafenamide from either RPV, FTC and tenofovir disoproxil fumarate (TDF) or efavirenz, FTC and TDF: 96-week results from two randomized clinical trials.

Hagins D, Orkin C, Daar ES, Mills A, Brinson C, DeJesus E, Post FA, Morales-Ramirez J, Thompson M, Osiyemi O, Rashbaum B, Stellbrink HJ, Martorell C, Liu H, Liu YP, Porter D, Collins SE, SenGupta D, Das M.

HIV Med. 2018 Aug 12. doi: 10.1111/hiv.12664. [Epub ahead of print]

PMID:
30101539
2.

Acceptability of high-resolution anoscopy for anal cancer screening in HIV-infected patients.

Lam JO, Barnell GM, Merchant M, Ellis CG, Silverberg MJ.

HIV Med. 2018 Aug 6. doi: 10.1111/hiv.12663. [Epub ahead of print]

PMID:
30084191
3.

CD4:CD8 ratio in children with perinatally acquired HIV-1 infection.

Seers T, Vassallo P, Pollock K, Thornhill JP, Fidler S, Foster C.

HIV Med. 2018 Aug 6. doi: 10.1111/hiv.12642. [Epub ahead of print]

PMID:
30084150
4.

Interest of cytology combined with Xpert® HPV and Anyplex® II HPV28 Detection human papillomavirus (HPV) typing: differential profiles of anal and cervical HPV lesions in HIV-infected patients on antiretroviral therapy.

Nassereddine H, Charpentier C, Bucau M, Joly V, Bienvenu L, Davitian C, Abramowitz L, Benabderrahmane D, Kotelevets L, Chastre E, Lehy T, Walker F.

HIV Med. 2018 Jul 30. doi: 10.1111/hiv.12661. [Epub ahead of print]

PMID:
30062761
5.

Quantifying the drivers of HIV transmission and prevention in men who have sex with men: a population model-based analysis in Switzerland.

Kusejko K, Marzel A, Hampel B, Bachmann N, Nguyen H, Fehr J, Braun DL, Battegay M, Bernasconi E, Calmy A, Cavassini M, Hoffmann M, Böni J, Yerly S, Klimkait T, Perreau M, Rauch A, Günthard HF, Kouyos RD; Swiss HIV Cohort Study.

HIV Med. 2018 Jul 26. doi: 10.1111/hiv.12660. [Epub ahead of print]

PMID:
30051600
6.

Prevalence of diagnosed HIV infection among persons with hepatitis C virus infection: England, 2008-2014.

Ireland G, Delpech V, Kirwan P, Croxford S, Lattimore S, Sabin C, Porter K, Mandal S, Simmons R.

HIV Med. 2018 Jul 26. doi: 10.1111/hiv.12662. [Epub ahead of print]

PMID:
30051565
7.

Association between exposure to antiretroviral drugs and the incidence of hypertension in HIV-positive persons: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study.

Hatleberg CI, Ryom L, d'Arminio Monforte A, Fontas E, Reiss P, Kirk O, El-Sadr W, Phillips A, de Wit S, Dabis F, Weber R, Law M, Lundgren JD, Sabin C; Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Study Group.

HIV Med. 2018 Jul 18. doi: 10.1111/hiv.12639. [Epub ahead of print]

PMID:
30019813
8.

The role of brain biopsy in the clinical management of HIV-related focal brain lesions.

Acosta MC, Kundro M, Viloria G, Peressín Paz A, Morello F, Latorre F, Seoane E, Toibaro J, Losso M.

HIV Med. 2018 Jul 13. doi: 10.1111/hiv.12646. [Epub ahead of print]

PMID:
30004180
9.
10.

To prescribe, or not to prescribe: decision making in HIV-1 post-exposure prophylaxis.

Scholten M, Suárez I, Platten M, Kümmerle T, Jung N, Wyen C, Ernst A, Horn C, Burst V, Suárez V, Rybniker J, Fätkenheuer G, Lehmann C.

HIV Med. 2018 Jul 11. doi: 10.1111/hiv.12645. [Epub ahead of print]

PMID:
29993176
11.

HIV health care providers are ready to introduce pre-exposure prophylaxis in Central and Eastern Europe and neighbouring countries: data from the Euroguidelines in Central and Eastern Europe (ECEE) Network Group.

Kowalska JD, Bursa D, Gökengin D, Jilich D, Tomazic J, Vasylyev M, Bukovinowa P, Mulabdic V, Antonyak S, Horban A; ECEE Network Group.

HIV Med. 2018 Jul 10. doi: 10.1111/hiv.12641. [Epub ahead of print]

PMID:
29989332
12.

To T or not to T: Differences in Testosterone Use and Discontinuation by HIV Serostatus among Men who Have Sex with Men.

Haberlen SA, Jacobson LP, Palella FJ Jr, Dobs A, Plankey M, Lake JE, Kingsley LA, Stall R, Post WS, Brown TT.

HIV Med. 2018 Jul 10. doi: 10.1111/hiv.12644. [Epub ahead of print]

PMID:
29989322
13.

Association between smoking status assessed with plasma-cotinine and inflammatory and endothelial biomarkers in HIV-positive and HIV-negative individuals.

Ahlström MG, Knudsen A, Ullum H, Gerstoft J, Kjaer A, Lebech AM, Hasbak P, Obel N.

HIV Med. 2018 Jul 9. doi: 10.1111/hiv.12647. [Epub ahead of print]

PMID:
29984882
14.

Similar long-term efficacy of dual therapy containing raltegravir and a boosted protease inhibitor versus standard triple therapies in pretreated HIV-1-infected patients in a retrospective, real-life cohort of 14 years.

Krznaric I, Bickel M, Carganico A, De Leuw P, Haberl A, Knecht G, Koegl C, Lauscher P, Schüttfort G, Stephan C, Wolf E, Wolf T.

HIV Med. 2018 Jul 3. doi: 10.1111/hiv.12636. [Epub ahead of print]

PMID:
29971922
15.

Comparison of Löwenstein-Jensen and BACTEC MGIT 960 culture for Mycobacterium tuberculosis in people living with HIV.

Hongler J, Musaazi J, Ledergerber B, Eberhard N, Sekaggya-Wiltshire C, Keller PM, Fehr J, Castelnuovo B.

HIV Med. 2018 Jul 3. doi: 10.1111/hiv.12635. [Epub ahead of print]

PMID:
29971898
16.

Using behavioural insights to increase HIV self-sampling kit returns: a randomized controlled text message trial to improve England's HIV self-sampling service.

Brown LJ, Tan KS, Guerra LE, Naidoo CJ, Nardone A.

HIV Med. 2018 Jul 2. doi: 10.1111/hiv.12634. [Epub ahead of print]

PMID:
29963766
17.

Liver stiffness reduction and serum fibrosis score improvement in HIV/hepatitis C virus-coinfected patients treated with direct-acting antivirals.

Fabbri G, Mastrorosa I, Vergori A, Timelli L, Lorenzini P, Zaccarelli M, Cicalini S, Bellagamba R, Plazzi MM, Mazzotta V, Antinori A, Ammassari A.

HIV Med. 2018 Jun 28. doi: 10.1111/hiv.12632. [Epub ahead of print]

PMID:
29953713
18.

Evolution of transmitted HIV-1 drug resistance and viral subtypes circulation in Italy from 2006 to 2016.

Rossetti B, Di Giambenedetto S, Torti C, Postorino MC, Punzi G, Saladini F, Gennari W, Borghi V, Monno L, Pignataro AR, Polilli E, Colafigli M, Poggi A, Tini S, Zazzi M, De Luca A; Antiviral Response Cohort Analysis (ARCA) Collaborative Group.

HIV Med. 2018 Jun 22. doi: 10.1111/hiv.12640. [Epub ahead of print]

PMID:
29932313
19.

Stable HIV-1 reservoirs on dolutegravir maintenance monotherapy: the MONODO study.

Sculier D, Doco-Lecompte T, Yerly S, Metzner KJ, Decosterd LA, Calmy A.

HIV Med. 2018 Jun 22. doi: 10.1111/hiv.12626. [Epub ahead of print]

PMID:
29932298
20.

Switching to abacavir versus use of a nucleoside-sparing dual regimen for HIV-infected patients with tenofovir-associated renal toxicity.

Casado JL, Santiuste C, Vivancos MJ, Monsalvo M, Moreno A, Perez-Elías MJ, Del Rey JM, Moreno S.

HIV Med. 2018 Jun 22. doi: 10.1111/hiv.12630. [Epub ahead of print]

PMID:
29932293

Supplemental Content

Loading ...
Support Center